Clinical trial
A Novel and Practical Accelerated Intermittent Theta Burst Protocol as a Substitute for Depressed Patients Needing Electroconvulsive Therapy During the COVID-19 Pandemic
NCT04384965 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel and Practical Accelerated Intermittent Theta Burst Protocol as a Substitute for Depressed Patients Needing Electroconvulsive Therapy During the COVID-19 Pandemic
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 12, 2020
- Completion date
- November 1, 2022
- Enrollment
- 176 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.